Fine Foods & Pharmaceuticals Ntm

What Fine Foods & Pharmaceuticals Ntm does

Fine Foods & Pharmaceuticals N.T.M. S.p.A. is an Italian contract development and manufacturing organization (CDMO) engaged in the development and production of pharmaceutical, nutraceutical, and medical device products. Founded in 1985 and headquartered in Bergamo, Italy, the company operates production facilities including a dedicated Pharma Business Unit in Brembate. It employs between 501 and 1,000 people and serves international clients under multi-year supply agreements, functioning as a B2B contract manufacturing partner for established pharmaceutical and consumer health brands.

The company's revenue is anchored in contract manufacturing fees across its pharmaceutical, nutraceutical, and medical device segments. According to available financial data, Fine Foods generated approximately $252M in revenue in 2025, with revenues growing from $206M in 2022. The business has executed a significant profitability turnaround — net income moved from -$9.5M in 2022 to +$10.1M in 2025, while EBITDA expanded roughly tenfold from $3.3M to $34.5M over the same period. The company's enterprise value stood at approximately $275M as of the most recent disclosure.

In June 2025, Fine Foods secured €30M in financing from Intesa Sanpaolo to expand its Brembate pharma production facility, supporting multi-year international client agreements. The company subsequently announced an acquisition of Sofar in April 2026. The company trades publicly on Borsa Italiana under the ticker FF, with Giorgio Ferraris serving as Chief Executive Officer.

Name

Fine Foods & Pharmaceuticals Ntm

Legal name

Fine Foods & Pharmaceuticals N.T.M. S.p.A.

Website

https://finefoods.it

Company type

Private

Founded year

1985

Operating status

Operating

Headcount range

501–1,000 employees

Short description

Italian contract development and manufacturing organization (CDMO) specializing in pharmaceutical, nutraceutical, and medical device production. Founded in 1985 in Bergamo, Italy, it serves international clients through multi-year supply agreements and reported approximately $252M in revenue in 2025.

Ownership category

akta.pro rank

Product category

Pharmaceutical Contract Manufacturing

NAICS

Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (32541), Medical Equipment and Supplies Manufacturing (3391)

SIC

Pharmaceutical Preparations (2834), Food And Kindred Products (2000)

akta.pro primary industry

Generic Finished Dosage Form (FDF) Manufacturing (HLAIABAH)

akta.pro secondary industries

Medical & Clinical Nutrition Beverage Production (Oral Nutritional Supplements) (AFAFAFAJ), Foods for Special Dietary Needs Manufacturing (Gluten-Free, Allergen-Free, Low-FODMAP, Low-Sodium) (AFAKAJAD)

Keywords

• Pharmaceutical contract manufacturing
• Nutraceutical production
• Medical device manufacturing
• CDMO services
• Pharmaceutical development

Headquarters

HQ city

Bergamo

HQ country

Italy

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Supply Chain, Technology or R&D, Infrastructure

Core offering

Fine Foods & Pharmaceuticals N.T.M. S.p.A. develops and manufactures pharmaceutical products, nutraceutical products, and medical devices at its production facility in Brembate, Bergamo, Italy. The company operates a dedicated Pharma Business Unit and supplies international pharmaceutical clients under multi-year manufacturing agreements, with capacity currently being expanded through €30 million in debt financing from Intesa Sanpaolo.

Product overview

Fine Foods & Pharmaceuticals N.T.M. S.p.A. is an Italian food and pharmaceutical manufacturing company. Based on available sources, the company operates a production facility in Brembate, Bergamo, Italy, with a dedicated Pharma Business Unit. The company has secured €30 million in financing from Intesa Sanpaolo for expansion of its pharmaceutical production facilities, supporting significant multi-year agreements with international clients. No specific product names, brand offerings, or detailed product/service descriptions were available in the provided source material.

Differentiator

Problem solved

Functional benefit

Products and services

• Pharmaceutical product manufacturing
• Nutraceutical product manufacturing
• Medical device manufacturing

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Scale indicators1 record

Recent moves4 records

Expansion highlights4 records

Market position

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Fine Foods & Pharmaceuticals Ntm